1/n Our deprescribing.org team gets asked about statins A LOT We did a systematic review on statin discontinuation which came out last month in JAGS Join me for few take-aways 👇 #deprescribing #CardioTwitter agsjournals.onlinelibrary.wiley.com/doi/10.1111/jg…

Voices like Laurie Garrett advocated against the reopening of schools, an utterly disastrous #COVID19 policy failure. With that said I’d never advocate that universities disallow her to speak her views on campus. Academic freedom is the bedrock that a university is built upon

A fav too! "One of my favourite studies asked doctors whether they were influenced by the small gifts...delivered by drug reps. Most said no. But when asked whether their colleagues were influenced by the same small gifts? Most said yes. Both statements obviously cannot be true."

Every Target Trial Emulation Study: "Randomization was emulated using propensity score matching adjusting for baseline covariates" Narrator: this was an observational study where nothing close to randomization was done

Stump the VitalTalk Communication Experts: Gordon Wood, Holly Yang, Elise Carey VitalTalk geripal.org/stump-the-vita…

We try to Stump Three #VitalTalk Communication Experts with some of the most challenging communication scenarios that we (and some of our listeners) could think up. Guests Gordon Wood, Holly Yang, MD, Elise Carey, MD. #hapc Episode bit.ly/GeriPalEp324 - hosts Alex Smith, MD | Eric Widera, MD

Thanks for having us GeriPal - A Geriatrics & Palliative Care Podcast! We had a great time! #hapc #meded #geripal Elise Carey, MD Gordon cc: VitalTalk

Summer COVID surge shows we may have to return to 2020 pandemic measures What? No, definitely not. Anyone who understands the basis of immunology would strongly disagree. thehill.com/opinion/health… 1/8

Can we all agree never to use websites like Doodle (Doodle) that are littered with ads that make it seem like an ad's "continue" buttons are the official ones to press to submit a form?

For every study that helps us decide whether to start a new medication, there should be an equal & opposite study to help us decide when to stop a medication. With that new law of medicine, I present you this study on beta-blocker discontinuation after MI nejm.org/doi/full/10.10…

“They’d come home weak and tired and go to bed,” she said. “It’s a day until they feel back to normal, and then it’s time to go back to dialysis again. I didn’t want that regimen.” Via Paula Span nytimes.com/2024/09/01/hea…

Halfway through 2024 and the media including the The New York Times still ignore EPIC-SR showing no benefit of Paxlovid for #COVID19 in standard risk patients which included higher risk patient who are vaccinated. BTW - we knew the study results at the start of 2022 nytimes.com/2024/08/16/wel…

California may soon ban affirmative action for the rich: California legislature passes bill to banning legacy admissions at private colleges timesofsandiego.com/education/2024…

The fact that Eisai refuses to release data on whether amyloid clearance correlates to cognitive benefits at the level of individual participants taking Lecanemab at this point can only mean one thing: that it clearly does not favorably correlate. #Alzheimers

Drug trials: No preregistration except for the outcome variable and no data transparency. What could go wrong?

Haldol shrimp sliders are the bomb

“This is the most controversial element of the document, and it's hidden in Box 4 on page 10 of the paper,” said Eric Widera, MD. “… The worry is that clinicians will miss it and there will be people who are tested and told they have Alzheimer's despite having no symptoms”

Eric Widera, MD “But we know that many people who have amyloid and tau in the brain will never develop dementia in their lifetime,” Eric Widera, MD said. “We need a lot more research before we define tens of millions of people as having Alzheimer's based on biomarkers alone.”

Who do you want on a work group revising the definition of #Alzheimer’s disease? The system is broken when Pharma and diagnostic companies are the ones defining who is sick. The National Institute on Aging (NIA) knew this when NIH told them to take their name off the workgroup title journals.lww.com/neurotodayonli…

Marianne Chapleau The National Institute on Aging (NIA) A $20 meal from Pharma will influence my prescribing behavior as a doctor, not because I’m a bad person, or don’t care for what’s best for patients, but because I’m human. Ignoring conflicts of interest ignores everything we know about human psychology. jamanetwork.com/journals/jamai…